Call for Abstracts
Submit Your Abstract
Abstract Submission Deadline: 23:59 PST – July 27, 2026
Authors are asked to present their work with precise and clear objectives, directly related to their evidence and scientific support to support their research or clinical study. The Executive Committee and the Scientific Board of the Congress will evaluate each abstract presented.
Important Dates
April 27, 2026
Call for Abstracts Launch
July 27, 2026
DEADLINE:
Abstract Submission
August 17, 2026
Abstract Acceptance Notification Letters
September 17, 2026
DEADLINE:
Accepted Abstract Presenters Deadline to Change Title, Change Presenting Author, and/or Make Abstract Corrections
DEADLINE:
Accepted Abstract Presenters Deadline to Accept or Decline Presentation
Accepted Abstract Topics
Advocacy & Regulatory Aspects of Liquid Biopsy
Clinical Applications of Liquid Biopsy
Clinical Trials in Progress (TIP) Using Liquid Biopsies
New Biomarkers Using Liquid Biopsy
Comprehensive Liquid Biopsy Analysis in Different Matrices
Liquid Biopsy in Early Cancer Detection
Liquid Biopsy in Non-Oncological Conditions
Miscellaneous
Guidelines
Language
Abstracts are accepted in English only
Abstract Title Limit
The maximum word limit for Abstract title is 20 (excluding spaces)
Abstract Text Limit
The maximum word limit for Abstract text is 300 + 1 image or table (excluding spaces) or 350 with no images or tables (excluding spaces)
Image / Table Allowance
1 image or table is equal to 50 words
Submission Method
Abstracts submitted via email or paper are not accepted
Presenting Author
There can be only 1 Presenting Author
Co-authors
The maximum number of Co-authors is 10
Number of Submissions
There is no limit to the number of abstracts submitted by an Author
Required Sections
Required sections for Abstract submission: Introduction, Methods, Results, Conclusion
Registration
Submitting an abstract does not register you for ISLB 2026
Accepted Abstract Benefit
If your abstract is accepted as an Oral Presentation or Poster, you will be entitled to a discounted rate.
Conflict of Interest
- Authors must agree to allow publication of accepted abstract(s) on the conference website.
- All authors must complete a conflict of interest during their abstract submission (no form necessary)
- If your research has been granted any commercial or institutional support, you will be asked to disclose this during the submission process
- Grants must be disclosed
REVIEW
The Executive Committee and Scientific Board will review each abstract and select Poster and Oral Presentations.
- Prizes are awarded to the highest scoring abstract
- No extra steps are necessary to apply to the Award
Frequently Asked Questions
Will case reports be considered for abstract submissions?
Case reports are acceptable.
Does ISLB accept abstracts that have been submitted and presented to a previous Conference (i.e., encore abstracts, trials in progress, encore abstracts)?
An abstract that has previously been presented at another meeting will only be considered if there have been significant updates to the presentation. Submitters are required to list all previous presentations in the introduction section of the abstract.
When will I receive the Notification Letter?
Notification Letters will be sent August 17, 2026.
Where will my abstract be published?
Accepted abstracts will be published on The Journal of International Liquid Biopsy
I am having trouble submitting my abstract – what can I do?
Please send an email to islb-program@icsevents.com
If you have any questions regarding your submitted abstract or the abstract submission process, do not hesitate to reach to islb-program@icsevents.com